.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Teva
Express Scripts
US Department of Justice
Boehringer Ingelheim
Farmers Insurance
Moodys
Queensland Health
Mallinckrodt
McKesson

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,712,251

« Back to Dashboard

Summary for Patent: 5,712,251

Title: Treatment method
Abstract:A method of treating prostate cancer in warm-blooded animals comprising administering to warm-blooded animals an effective amount of a peptide of Formula I and an anti-androgen.
Inventor(s): Labrie; Fernand (Quebec, CA), Raynaud; Jean-Pierre (Paris, FR)
Assignee: Roussel Uclaf (FR)
Application Number:08/444,198
Patent Claim Types:
see list of patent claims
Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,712,251

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France79 23545Sep 21, 1979

International Patent Family for Patent: 5,712,251

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia3726985► Subscribe
Australia542765► Subscribe
Australia572938► Subscribe
Australia6256580► Subscribe
Belgium885308► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Queensland Health
Healthtrust
Farmers Insurance
Cipla
Julphar
Harvard Business School
Citi
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot